Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors
US8846698B2 · kind B2 · utility
10Cited by
1References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2012 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Nov 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I)and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.